Wall G C, Heyneman C A
Adult Internal Medicine, Scott and White Hospital, Temple, TX, USA.
Ann Pharmacother. 1999 Apr;33(4):499-501. doi: 10.1345/aph.18204.
PLP is a challenging disorder that is often difficult to treat. Like all other types of pain, PLP is a tremendous source of morbidity and should be treated aggressively. Though evidence is very limited, one or two doses of intravenous salmon calcitonin 200 IU may be an effective treatment. The minor adverse effects reported in the literature would seem to indicate the relative safety of this regimen; however, clinicians should be aware of the rare but severe hypersensitivity reactions that can occur with salmon calcitonin. Intranasal calcitonin appears to be similar in efficacy to the parenteral formulation, at least in pain associated with vertebral crush fractures. Long-term studies using intranasal calcitonin for relief of PLP are warranted given the ease of administration of this dosage form.
幻肢痛是一种具有挑战性的病症,通常难以治疗。与所有其他类型的疼痛一样,幻肢痛是发病的一个重要原因,应积极治疗。尽管证据非常有限,但一或两剂200国际单位的静脉注射鲑鱼降钙素可能是一种有效的治疗方法。文献中报道的轻微不良反应似乎表明该治疗方案具有相对安全性;然而,临床医生应意识到鲑鱼降钙素可能会发生罕见但严重的过敏反应。鼻内降钙素的疗效似乎与肠胃外制剂相似,至少在与椎体压缩性骨折相关的疼痛方面如此。鉴于这种剂型易于给药,有必要进行使用鼻内降钙素缓解幻肢痛的长期研究。